RKTONasdaqPharmaceutical PreparationsFiscal year ends December 31

Rocket One Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.50−0.01 (-1.97%)

Close on Oct 19, 2026

Market cap: $10.21M
P/E (TTM): –
Dividend yield: –

Rocket One Inc. cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31
Stock-Based Compensation	0.68	0	0	1.13	0.06	0.22	0.00	0.28	0.01	0.19	0.01	0.01	0.02	0.01	0.02	0.58	0.14	0.04	0.03	1.13	0.04	0.66	0.02	0.02	2.00	0.21	0.09	0.20	0.00	0.01	0.12	0.02
Change in Accounts Payable	-0.05	-0.01	0.45	0.66	-0.44	-0.02	0.02	0.13	-1.24	0.21	0.38	-0.05	0.35	0.28	0.01	-0.05	-0.75	0.41	0.41	0.45	0.10	-0.15	-0.22	0.11	0.38	-0.18	0.14	-0.07	0.12	-0.10	0.05	0.03
Operating Cash Flow	-2.97	-3.05	-2.15	-2.49	-2.37	-2.79	-2.03	-1.63	-3.07	-1.64	-1.45	-2.29	-2.55	-2.39	-2.22	-2.14	-3.90	-2.70	-2.76	-2.72	-0.66	-1.50	-2.40	-1.58	-1.50	-1.64	-1.05	-0.76	-0.46	-0.70	-0.60	-0.35
Purchase of Investments	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–	–	–	–	–	–	–
Sale & Maturity of Investments	–	–	–	–	–	–	–	–	–	–	–	–	0.00	0.00	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Investing Cash Flow	0	0.15	0	–	–	–	–	–	–	–	–	–	-0.01	0.01	1.18	-0.03	-0.02	-0.58	-0.53	0.96	-0.82	0.67	-1.70	0.01	-0.03	-0.85	-0.01	-0.01	–	–	–	–
Stock Issued	5.15	0.70	0.61	2.00	0.07	1.44	–	–	0	2.41	–	–	0	0	–	–	0	0	-0.14	4.57	0	0	–	–	0	0.00	-0.02	5.86	–	–	–	–
Taxes Paid on Share-Based Awards	–	–	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Financing Cash Flow	6.81	0.70	0.55	1.63	0.07	7.07	1.06	0	0	2.41	0	8.91	0.05	0	–	–	0	-0.10	-0.14	18	0	0	4.49	4.23	0	1.61	-0.02	5.86	0	-0.03	0	1.19
Foreign Exchange Rate Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	0.00	0.54	-0.49	-0.05	-0.01	0.00	0.00	-0.01	0.00	0.01	-0.02	-0.03	0.01	-0.01	0.00	–	–	–	–	–	–	–	–	–	–
Net Change in Cash	–	–	–	–	–	–	–	–	–	–	–	6.62	-2.51	-2.38	4.95	-2.16	-3.92	-3.38	-3.43	17	-1.48	-0.82	0.40	2.66	-1.52	-0.88	-1.07	5.08	-0.46	-0.73	-0.60	0.83

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -191.4%

Financial strength

Current ratio: 6.20
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 570.3%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 1.25
Dividend yield: –